XT-101: a potent IL-10 based therapy for treating multiple sclerosis
Ended Project Grant Awarded Last action
- Award ID
- R43NS081878
- Recipient
-
Xalud Therapeutics, Inc. UEI LVJKCZJKEKV3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $689,217
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- Berkeley, CA 94704, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $350,000 | |
| Original award | $339,217 |
Quick answers
Who received award R43NS081878?
R43NS081878 was awarded to Xalud Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on February 15, 2013.
How much is award R43NS081878 worth?
$689,217 has been obligated on R43NS081878.
Which agency awarded R43NS081878?
National Institutes of Health (Department of Health and Human Services) awarded R43NS081878, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award